Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
12 December 2020 |
Main ID: |
NCT01759108 |
Date of registration:
|
23/12/2012 |
Prospective Registration:
|
Yes |
Primary sponsor: |
|
Public title:
|
Rebamipide AND Sjögren Syndrome
|
Scientific title:
|
Rebamipide for the Treatment of Xerostomia in Sjögren Syndrome |
Date of first enrolment:
|
March 13, 2020 |
Target sample size:
|
55 |
Recruitment status: |
Recruiting |
URL:
|
https://clinicaltrials.gov/show/NCT01759108 |
Study type:
|
Interventional |
Study design:
|
Allocation: Randomized. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
|
Phase:
|
N/A
|
|
Countries of recruitment
|
Egypt
| | | | | | | |
Contacts
|
Name:
|
Anna Abou-Raya, MD PhD |
Address:
|
|
Telephone:
|
5924601 |
Email:
|
annaaraya@yahoo.com |
Affiliation:
|
|
|
Name:
|
Anna Abou-Raya, MD PhD |
Address:
|
|
Telephone:
|
5924601 |
Email:
|
annaaraya@yahoo.com |
Affiliation:
|
|
|
Name:
|
Anna Abou-Raya, MD PhD |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
University of Alexandria |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- SS patients with dry mouth symptoms
Exclusion Criteria:
- Patients with dry mouth due to other conditions
Age minimum:
N/A
Age maximum:
N/A
Gender:
All
|
Health Condition(s) or Problem(s) studied
|
Improving Symptoms of Dry Mouth in Sjogren's Syndrome
|
Intervention(s)
|
Drug: Rebamipide
|
Primary Outcome(s)
|
improvement of dry mouth symptoms
[Time Frame: 12 weeks]
|
Secondary ID(s)
|
116619963
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|